Skip to content

Clinical trials

Completed Phase 1 Hypertension, Pulmonary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 1 Status: Completed Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20063
20071
20083
20093
20101
20114
20121
20131
20152
20161
20172
20182
20194
20202
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
GlaxoSmithKline3
National Heart, Lung, and Blood Institute (NHLBI)3
United Therapeutics2
Aadi Bioscience, Inc.1
Actelion1
Aires Pharmaceuticals, Inc.1
Attgeno AB1
Bellerophon1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary36
Pulmonary Arterial Hypertension8
Anemia, Sickle Cell4
Pulmonary Disease, Chronic Obstructive3
Acute Chest Syndrome2
Bronchopulmonary Dysplasia2
Familial Primary Pulmonary Hypertension2
Heart Failure2
Idiopathic Pulmonary Fibrosis2
Lung Diseases2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.